跳至主要内容
临床试验/CTRI/2024/06/068745
CTRI/2024/06/068745已完成2/3 期

Study on the Efficacy of Pratishyayahara Vati on Vataja Pratishyaya, Allergic Rhinitis in Children - An Open Label Randomised Controlled Clinical Trial

Dr Meghana S K1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年6月20日最近更新:

试验速览

阶段
2/3 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Reduction in the clinical symptoms of Vataja Pratishyaya based on

研究概览

简要总结

An open label randomised controlled clinical trial on the efficacy of Pratishyayahara vati on Vataja Pratishyaya, allergic rhinitis in children of age group 6-12 years for a period of 15 days. During this study period, 40 children will be recruited and divided into two groups, Group A (Trial drug) and Group B (Control drug), 20 children each. Group A(Trial drug) children will be administered Pratishyayahara Vati (500mg BID AF) and Group B(Control drug) children will be administered Tryushanadi Vati (500mg BID AF) for a period of 15 days. Clinical assessment will be done for both subjective & objective criteria on 0th day, 7th day & 15th day. Statistical analysis will be done through data obtained on 0 day(BT) and 15th day(AT).

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
6.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • Patients with age group of 6 to 12 years fulfilling the diagnostic criteria, irrespective of gender, religion, socio economic status.
  • Children with clinical features of Vataja Pratishyaya with duration less than 15 days.

排除标准

  • Children of age below 6 years and above 12 years.
  • All other types of Pratishyaya, except Vataja Pratishyaya.
  • Children suffering from any chronic debilitating or infectious diseases like Deviated Nasal Septum, Nasal polyp, Sinusitis, fever(temp more than 100F), Tuberculosis, COPD, Congenital lung and cardiac anomalies etc which may interfere with present clinical trial.

结局指标

主要结局

Reduction in the clinical symptoms of Vataja Pratishyaya based on

时间窗: Baseline, 15 days

1. Vataja Pratishyaya Gradation index.

时间窗: Baseline, 15 days

2. TNSS (Total Nasal Symptom Score-Questionnaire)

时间窗: Baseline, 15 days

次要结局

  • Significant clinical relief in signs and symptoms of Vataja pratishyaya based on(1. RCAT (Rhinitis Control Assessment Test))

研究者

发起方
Dr Meghana S K
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Meghana S K

Shri Dharmasthala Manjunatheshwara Institute of Ayurveda and Hospital, Bangalore

研究点 (1)

Loading locations...

相似试验

Study on the Efficacy of Pratishyayahara Vati on... | 临床试验